首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor
Authors:Barnett Brad P  Hwang Yousang  Taylor Martin S  Kirchner Henriette  Pfluger Paul T  Bernard Vincent  Lin Yu-yi  Bowers Erin M  Mukherjee Chandrani  Song Woo-Jin  Longo Patti A  Leahy Daniel J  Hussain Mehboob A  Tschöp Matthias H  Boeke Jef D  Cole Philip A
Institution:Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Abstract:Ghrelin is a gastric peptide hormone that stimulates weight gain in vertebrates. The biological activities of ghrelin require octanoylation of the peptide on Ser(3), an unusual posttranslational modification that is catalyzed by the enzyme ghrelin O-acyltransferase (GOAT). Here, we describe the design, synthesis, and characterization of GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizes GOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice. Intraperitoneal administration of GO-CoA-Tat improves glucose tolerance and reduces weight gain in wild-type mice but not in ghrelin-deficient mice, supporting the concept that its beneficial metabolic effects are due specifically to GOAT inhibition. In addition to serving as a research tool for mapping ghrelin actions, GO-CoA-Tat may help pave the way for clinical targeting of GOAT in metabolic diseases.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号